Skip to content

Glucose Testing in GDM: Adherence to One- Versus Two-hour Postprandial Glucose Monitoring in Gestational Diabetics

Adherence to One- Versus Two-hour Postprandial Glucose Monitoring in Gestational Diabetics: A Randomized Trial

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05062460
Enrollment
140
Registered
2021-09-30
Start date
2021-07-15
Completion date
2025-05-01
Last updated
2025-05-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Gestational Diabetes

Brief summary

The purpose of this study is to evaluate if in patients with gestational diabetes (GDM), adherence to postprandial glucose monitoring differs when performed 1-hour versus 2-hours after eating. The primary objective of this study is to evaluate difference in rate of adherence (binary outcome defined as \<80% or ≥80% of glucose log completed) between gestational diabetics who perform 1-hour versus 2-hour postprandial blood glucose testing.

Detailed description

Consented patients who are diagnosed with gestational diabetes will be randomized to either 1-hour or 2-hour postprandial blood glucose monitoring. A retrospective chart review from July 2020 until study commencement for patients from the same clinic will be used as a historical control group. This study will assess differences in adherence to testing.

Interventions

OTHER1 hour Blood glucose monitoring

Consented patients who are diagnosed with gestational diabetes will be randomized to 1-hour postprandial blood glucose monitoring.

OTHER2 hour blood glucose monitoring

Consented patients who are diagnosed with gestational diabetes will be randomized to 2 hour post prandial blood glucose monitoring

Sponsors

Weill Medical College of Cornell University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE

Eligibility

Sex/Gender
FEMALE
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Pregnant patients with singleton gestation who are ≥ 18 years of age. * Diagnosis of GDM after 24 0/7 weeks. * For diagnosing GDM, a two-step screening algorithm will be performed according to the American College of Obstetrics and Gynecologists.4 Specifically, a 1-hour 50-g glucose-loading test is given first. Plasma glucose levels between 140 and 200 mg/dL will be considered elevated. Confirmatory testing will then be performed using a 3-hour 100-g glucose tolerance test. Diagnosis was made when two of the four values were elevated. Abnormal glucose value thresholds are established via the criteria suggested by Carpenter and Coustan: fasting value ≥ 95 mg/dL, 1-hour ≥ 180 mg/dL, 2-hour ≥ 155 mg/dL, and 3-hour ≥ 140 mg/dL.9 Patients with a blood glucose level greater than 200 mg/dL after 1-hour 50-g glucose-loading test will be diagnosed with GDM without requirement for the 3-hour 100-g glucose tolerance test.

Exclusion criteria

* Type 1 pre-gestational diabetes * Type 2 pre-gestational diabetes * GDM diagnosed prior to 24 0/7 weeks gestation.

Design outcomes

Primary

MeasureTime frameDescription
Rate of adherenceDuring the interventionEvaluate rate of adherence (binary outcome defined as \<80% or ≥80% of glucose log completed) between gestational diabetics who perform 1-hour versus 2-hour postprandial blood glucose testing.

Secondary

MeasureTime frame
Percentage of postprandial glucose log complete for each meal (breakfast, lunch, and dinner), averaged over the duration of the study periodDuring the intervention
Percentage of elevated blood glucose values per week, averaged over the duration of the study periodDuring the intervention
Number of patients who start insulin or oral hyperglycemic medication therapy prior to delivery.During the intervention
Gestational age at medication therapy initiationDuring the intervention
Timeframe from diagnosis of gestational diabetes to initiation of insulin therapyDuring the intervention
Number of subjects with a vaginal deliveryAt time of delivery
Number of subjects with an operative deliveryAt time of delivery
Number of subjects with a caesarean section deliveryAt time of delivery
Number of subjects with a preeclampsia diagnosisDuring intervention
Neonatal birthweightAt time of delivery
Percentage of postprandial glucose log complete, averaged over the duration of the study periodDuring the intervention
Number of patients with 3rd or 4th degree perineal lacerationsAt time of delivery
Number of patients with postpartum hemorrhage.At time of delivery
Number of stillbirthsAt time of delivery
Number of NICU admissionsAt time of delivery
Number of patients requiring supplemental oxygen supportAt time of delivery
Number of patients with diagnosis of hypoglycemiaAt time of delivery
Number of patients with diagnosis of hyperbilirubinemiaAt time of delivery
Number of patients with clavicular fractureAt time of delivery
Number of patients with humeral fractureAt time of delivery
Number of patients with brachial plexus palsyAt time of delivery
Number of subjects with shoulder dystociaAt time of delivery

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026